Application of fluorinated polyethyleneimine in preparation of vaccine or preparation for preventing/treating diseases caused by viruses/bacteria
A technology of fluorinated polyethyleneimine and branched polyethyleneimine, which is applied in antiviral agents, antibacterial drugs, antibody medical components, etc., can solve the problem of lack of individualized curative effect prediction targets, endangering patients' lives, and declining vitality To achieve a strong immune memory effect and enhance the effect of antigen-specific T cell immune response
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] Embodiment 1: the construction of the nano-vaccine based on F-PEI
[0057] figure 1 It is a schematic diagram of the construction process of the nano vaccine, and the specific steps are as follows:
[0058] Mix F-PEI and OVA in an aqueous solution at room temperature and incubate for 5 to 30 minutes to obtain F-PEI / OVA nanovaccine
[0059] Specifically, F-PEI is F 7 -PEI or F 13 -PEI, its structural formula is as follows:
[0060]
[0061] Among them, R is a group with the following structural formula (the * mark represents the group connection site):
[0062]
[0063] Among them, F 7 - n of PEI is 2, F 13 -n is 5 for PEI. f 7 -PEI and F 13 - In PEI, x is 30 and 27. f 7 -PEI and F 13 - m in PEI is 46, that is, the molecular weight of the branched polyethyleneimine is 25 kDa.
[0064] Different nano-vaccines were prepared by changing the mass ratio of F-PEI to OVA. Table 1 shows the dynamic light scattering results of the F-PEI-based nano-vaccine cons...
Embodiment 2
[0068] Example 2: F-PEI can induce OVA-specific T cell immune response
[0069] The immunological evaluation plan is as follows:
[0070] The mice were injected with the nano-vaccine prepared in Example 1, and the lymph nodes were excised on the 3rd and 5th days after the injection, and the spleen was excised on the 7th day for immune evaluation.
[0071] Depend on image 3 As shown in a, b, c, F 13 -PEI / OVA nanovaccine can significantly induce the maturation of DC cells in vivo. And on the 5th day after vaccination, F 13 -More DC cells that induce antigen cross-presentation were detected in mice with PEI / OVA nanovaccine. Proof F 13 -PEI / OVA nanovaccine can induce innate immune response and can enhance antigen cross-presentation.
[0072] We then investigated whether OVA-specific adaptive immune responses were induced in mice. Depend on image 3 As shown in d and e, on the 7th day after vaccination, the OVA-specific IgG2a and IgG1 in mouse serum were detected by ELISA ...
Embodiment 3
[0074] Embodiment 3: The preventive effect of F-PEI / OVA nano-vaccine to B16-OVA melanoma
[0075] Respectively with saline (Blank), OVA, F 7 -PEI / OVA or F 13 -PEI / OVA intradermally immunized C57 / BL6 mice 3 times at intervals of 7 days. B16-OVA melanoma cells expressing OVA were injected 7 days after the last immunization.
[0076] like Figure 4 As shown, injected with F 13 -The average tumor volume of PEI / OVA nano-vaccine in mice inoculated with B16-OVA for 21 days was significantly smaller than that of other groups ( Figure 4 a) and inoculated with F 13 -The survival time of mice with PEI / OVA nanovaccine was significantly prolonged ( Figure 4 b).
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com